johnson and johnson glp 1 The Pros Cons of GLP-1 Medications: Dr. Reports GLP-1 therapies are transforming weight

Therefore, as the clinical use of incretin-based therapies continues to expand, careful patient selection, ongoing monitoring, and prompt identification of complications will be essential to ensuring safe and effective treatment

This can lead to acute liver failure

What you should do if you are taking a GLP-1 medication If you are currently on a GLP-1 receptor agonist for diabetes (or weight), the main takeaway is not stop. The practical takeaway is: Do not discontinue suddenly without talking to your clinician

11(12):2870 Nauck MA, Meier JJ (2018) Incretin hormones: their role in health and disease

[7] In countries with expanded newborn screening, SPCD can be identified shortly after birth